Genetic testing in cardiovascular disease

被引：36
作者：
Robin, Nathaniel H.
Tabereaux, Paul B.
Benza, Raymond
Korf, Bruce R.
机构：
[1] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Cardiol, Dept Med, Birmingham, AL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 50卷 / 08期
关键词：
RIGHT-VENTRICULAR CARDIOMYOPATHY; CORONARY-ARTERY-DISEASE; LONG-QT-SYNDROME; FAMILIAL DILATED CARDIOMYOPATHY; SUDDEN CARDIAC DEATH; ONSET HYPERTROPHIC CARDIOMYOPATHY; PRIMARY PULMONARY-HYPERTENSION; RYANODINE RECEPTOR GENE; LYMPHOTOXIN-ALPHA GENE; LAMIN A/C GENE;
D O I：
10.1016/j.jacc.2007.05.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Genetic testing is increasingly becoming possible for diagnosis, susceptibility testing, and prognostication in cardiovascular medicine. The practicing cardiologist, therefore, needs to be familiar with the clinical utilities and limitations of genetic testing. This review explores the major approaches to genetic testing and issues in test interpretation. Specific applications to cardiovascular diseases, including coronary artery disease, cardiomyopathies, cardiac arrhythmias, and pulmonary arterial hypertension are discussed.
引用
收藏
页码：727 / 737
页数：11
相关论文
共 86 条
  • [1] MEF2A sequence variants and coronary artery disease: a change of heart?
    Altshuler, D
    Hirschhorn, JN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) : 831 - 833
  • [2] INTERMITTENT MUSCULAR WEAKNESS, EXTRASYSTOLES, AND MULTIPLE DEVELOPMENTAL ANOMALIES - NEW SYNDROME
    ANDERSEN, ED
    KRASILNIKOFF, PA
    OVERVAD, H
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1971, 60 (05): : 559 - +
  • [3] CLINICAL-MOLECULAR CORRELATION IN 104 MILD X-LINKED MUSCULAR-DYSTROPHY PATIENTS - CHARACTERIZATION OF SUBCLINICAL PHENOTYPES
    ANGELINI, C
    FANIN, M
    PEGORARO, E
    FREDA, MP
    CADALDINI, M
    MARTINELLO, F
    [J]. NEUROMUSCULAR DISORDERS, 1994, 4 (04) : 349 - 358
  • [4] Familial dilated cardiomyopathy: Cardiac abnormalities are common in asymptomatic relatives and may represent early disease
    Baig, MK
    Goldman, JH
    Caforio, ALP
    Coonar, AS
    Keeling, PJ
    McKenna, WJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (01) : 195 - 201
  • [5] X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update
    Barth, PG
    Valianpour, F
    Bowen, VM
    Lam, J
    Duran, M
    Vaz, FM
    Wanders, RJA
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 126A (04): : 349 - 354
  • [6] Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1
    Beffagna, G
    Occhi, G
    Nava, A
    Vitiello, L
    Ditadi, A
    Basso, C
    Bauce, B
    Carraro, G
    Thiene, G
    Towbin, JA
    Danieli, GA
    Rampazzo, A
    [J]. CARDIOVASCULAR RESEARCH, 2005, 65 (02) : 366 - 373
  • [7] Dystrophinopathy, the expanding phenotype - Dystrophin abnormalities in X-linked dilated cardiomyopathy
    Beggs, AH
    [J]. CIRCULATION, 1997, 95 (10) : 2344 - 2347
  • [8] Bezzina C, 1999, CIRC RES, V85, P1206
  • [9] A novel X-linked gene, G4.5. is responsible for Barth syndrome
    Bione, S
    DAdamo, P
    Maestrini, E
    Gedeon, AK
    Bolhuis, PA
    Toniolo, D
    [J]. NATURE GENETICS, 1996, 12 (04) : 385 - 389
  • [10] World Heart Day 2002 - The international burden of cardiovascular disease: Responding to the emerging global epidemic
    Bonow, RO
    Smaha, LA
    Smith, SC
    Mensah, GA
    Lenfant, C
    [J]. CIRCULATION, 2002, 106 (13) : 1602 - 1605
123456789